Annette K. Taylor

发表

Markers of Celiac Disease and Gluten Sensitivity in Children with Autism

N. M. Lau, Peter H. R. Green, Dan Hellberg, 2013, PloS one.

Moving Pharmacogenetics Into Practice: It’s All About the Evidence!

S. V. Van Driest, L. Cavallari, J. Luzum, 2021, Clinical pharmacology and therapeutics.

American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing

W. Grody, B. Korf, J. Griffin, 2001, Genetics in Medicine.

Policy Statement: American college of medical genetics. Fragile X Syndrome: Diagnostic and carrier testing

V. Park, S. Sherman, Annette K. Taylor, 1994 .

Lack of Serologic Evidence to Link IgA Nephropathy with Celiac Disease or Immune Reactivity to Gluten

K. Kiryluk, Holly J. Snyder, P. Green, 2014, PloS one.

Biological and environmental contributions to adaptive behavior in fragile X syndrome

A. Reiss, D. Hessl, J. Dyer-Friedman, 2003, American journal of medical genetics. Part A.

Multicenter characterization and validation of the intron-8 poly(T) tract (IVS8-T) status in 25 Coriell cell repository cystic fibrosis reference cell lines for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation assays.

E. Lyon, F. Schaefer, S. Spitzer, 2004, Clinical chemistry.

Molecular-clinical correlations in males with fragile X syndrome

R. Hagerman, Annette K. Taylor, W. Sobesky, 1996 .

Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG)

C. Richards, Xuan Huang, E. Spector, 2018, Genetics in Medicine.

Autism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation

D. Loesch, Q. Bui, R. Huggins, 2007, Journal of autism and developmental disorders.

Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.

D. Loesch, F. Tassone, R. Hagerman, 2010, Human molecular genetics.

A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

P. Hagerman, F. Tassone, Khaled M. A. Amiri, 2008, The Journal of molecular diagnostics : JMD.

Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X.

D. Loesch, Q. Bui, R. Huggins, 2003, Neuropsychology.

Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X

D. Loesch, Q. Bui, R. Huggins, 2007, Neuroscience & Biobehavioral Reviews.

Genetic and environmental influences on the cognitive outcomes of children with fragile X syndrome.

Allan L Reiss, A. Reiss, D. Hessl, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Effect of the Deficits of Fragile X Mental Retardation Protein on Cognitive Status of Fragile X Males and Females Assessed by Robust Pedigree Analysis

D. Loesch, Q. Bui, R. Huggins, 2002, Journal of developmental and behavioral pediatrics : JDBP.

Discourse Processing in Women with Fragile X Syndrome: Evidence for a Deficit Establishing Coherence

B. Pennington, J. Keenan, R. Hagerman, 2001, Cognitive neuropsychology.

Tissue‐specific methylation differences in a fragile X premutation carrier

F. Tassone, J. Longshore, Annette K. Taylor, 1999, Clinical genetics.

Common-variant associations with fragile X syndrome

P. Sullivan, J. Piven, G. Crawford, 2017, bioRxiv.

The Case for Pharmacogenetics‐Guided Prescribing of Codeine in Children

K. Sangkuhl, T. Klein, K. Caudle, 2018, Clinical pharmacology and therapeutics.

Attitudes Toward Genetic Testing for Celiac Disease

A. Roy, B. Lebwohl, P. Green, 2016, Journal of Genetic Counseling.

Functional brain activation during cognition is related to FMR1 gene expression

Stephan Eliez, Vinod Menon, Allan L Reiss, 2000, Brain Research.

Addendum: American College of Medical Genetics consensus statement on factor V Leiden mutation testing

W. Grody, J. Griffin, Annette K. Taylor, 2021, Genetics in Medicine.

Annette K. Taylor, 1995 .

The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome.

A. Reiss, D. Hessl, J. Dyer-Friedman, 2001, Pediatrics.

FMRP expression as a potential prognostic indicator in fragile X syndrome.

B. Oostra, A. Taylor, R. Willemsen, 1999, American journal of medical genetics.

Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.

D. Loesch, P. Hagerman, A. Taylor, 2000, American journal of medical genetics.

High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.

S. Thibodeau, D. Nelson, C. Caskey, 1994, American journal of medical genetics.

Clinical involvement and protein expression in individuals with the FMR1 premutation.

P. Hagerman, A. Taylor, F. Tassone, 2000, American journal of medical genetics.

Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

T. Godfrey, P. Hagerman, A. Taylor, 2000, American journal of human genetics.

Molecular-clinical correlations in males with an expanded FMR1 mutation.

A. Taylor, R. Hagerman, Annette K. Taylor, 1996, American journal of medical genetics.

Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.

K. A. Lang, C. Quince, A. Taylor, 1994, JAMA.

Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report.

D. McIntosh, L. Miller, A. Taylor, 1999, American journal of medical genetics.

Molecular/clinical correlations in females with fragile X.

B. Pennington, L. Bennetto, A. Taylor, 1996, American journal of medical genetics.

Learning-disabled males with a fragile X CGG expansion in the upper premutation size range.

D. Nelson, A. Taylor, R. Hagerman, 1996, Pediatrics.

Phenotypic involvement in females with the FMR1 gene mutation.

Asma N. Cheema, B. Pennington, A. Taylor, 1998, American journal of mental retardation : AJMR.

Profile of cognitive functioning in women with the fragile X mutation.

B. Pennington, L. Bennetto, A. Taylor, 2001, Neuropsychology.

Hierarchical Bayes model for random haplotype and family effects in the transmission of fragile‐X

R. J. Mitchell, D. Loesch, A. Taylor, 2004, Genetic epidemiology.

Fragile X‐associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene

D. Loesch, G. Kinsella, A. Taylor, 2012, Clinical genetics.

Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome.

W. Greenough, S. Hersch, A. Taylor, 1999, American journal of medical genetics.

Fragile X syndrome in a normal IQ male with learning and emotional problems.

B. Pennington, D. Nelson, A. Taylor, 1994, Journal of the American Academy of Child and Adolescent Psychiatry.